Dr. Keith Flaherty's Quest for a Miracle Cancer Drug

The New York Times profiles a Harvard Medical School lecturer's quest for a miracle drug that saves lives—and the lives lost along the way.

The New York Times put a very human face on the hunt for new, more effective cancer drugs in its "Target Cancer" series last week. The doctor they featured, Keith Flaherty, is an oncologist at Massachusetts General Hospital (MGH) and a lecturer on medicine at Harvard Medical School.

The three-part series explores the debate over the most promising route to a cancer cure—targeted therapy, the subject of Flaherty's research, or immunotherapy, which seeks to leverage the immune system against cancer. The series examines the difficulty of balancing a desire for quick action to help sick patients with the need for caution when using unproven medicines—a situation complicated still more by competition among the pharmaceutical companies that want to make sure they earn back the significant capital they have invested in bringing these important drugs to market.

Author Amy Harmon's narrative takes readers along with Flaherty on a roller-coaster ride, as time runs out for some patients while startling successes come elsewhere. Harmon interweaves the stories of Flaherty—who started developing his approach to cancer during his residency at Brigham and Women's Hospital in the 1990s, and returned to Boston last year to take the MGH position—and the patients he treats, painting a picture of what motivates Flaherty to keep going despite having had to make, over the years, what has seemed like "an endless series of condolence calls that never became routine."

You might also like

Five Questions with Peter R. Girguis

A Harvard professor of evolutionary biology on what lurks in the deep sea  

How AI Is Reshaping Supply Chains

Harvard Kennedy School lecturer on using AI to strengthen supply chains

Do Mitochondria Hold the Power to Heal?

From Alzheimer’s to cancer, this tiny organelle might expand treatment options. 

Most popular

Shakespeare’s Greatest Rival

Without Christopher Marlowe, there might not have been a Bard.

How MAGA Went Mainstream at Harvard

Trump, TikTok, and the pandemic are reshaping Gen Z politics.

Harvard art historian Jennifer Roberts teaches the value of immersive attention

Teaching students the value of deceleration and immersive attention

Explore More From Current Issue

Colorful illustration of woman multitasking with laptop, baby bottle, toy, and checklist.

Motherhood and Ambition in a Pronatalist World

Gen Z is confronting the age-old question of balance—with a new twist.

Two women in traditional kimonos, one lighting a cigarette, in a scene from Apart from You.

Harvard Film Archive Spotlights Japanese Director Mikio Naruse

A retrospective of the filmmaker’s works, from Floating Clouds to Flowing

Catherine Zipf smiling, wearing striped shirt and dark sweater outdoors.

Preserving the History of Jim Crow Era Safe Havens

Architectural historian Catherine Zipf is building a database of Green Book sites.